Breaking News, Trials & Filings

PTC Begins Phase II/III Trial of PTC299 in COVID-19

PTC299 has a novel dual-mechanism of action that has the potential to address high viral replication and uncontrolled inflammatory response.

By: Contract Pharma

Contract Pharma Staff

...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters